Skip to contentA2A Pharmaceuticals, Inc. — Biomea Fusion, Inc. insider: 12 transactions · InsiderLensInsider trading activity of A2A Pharmaceuticals, Inc.
- Transactions on record
- 12
- since Sep 21, 2021
- Open-market buys
- 2
- $805.4K
- Open-market sells
- 10
- $32.8M
- Companies traded
- 1
- last filing Jun 2, 2023
Figures computed from official regulatory filings — methodology.
Companies where A2A Pharmaceuticals, Inc. has traded
Track record of A2A Pharmaceuticals, Inc.
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of A2A Pharmaceuticals, Inc.
Co-insiders of A2A Pharmaceuticals, Inc.
- AGUIAR ERICBiomea Fusion, Inc.
- Averill JulianneBiomea Fusion, Inc.
- Biomea Health, LLCBiomea Fusion, Inc.
- Butler Thomas AndrewBiomea Fusion, Inc.
- Chen BihuaBiomea Fusion, Inc.
- Cormorant Asset Management, LPBiomea Fusion, Inc.
- Cormorant Global Healthcare Master Fund, LPBiomea Fusion, Inc.
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Cormorant Private Healthcare Fund III LPBiomea Fusion, Inc.
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 2, 2023 | Sell | -75,000 | 33.81 USD | $2.5M | SEC |
| Jun 2, 2023 | Sell | -50,000 | 34.56 USD | $1.7M | SEC |
| May 17, 2023 | Sell | -25,000 | 33.84 USD | $846K | SEC |
| May 10, 2023 | Sell | -100,000 | 33.99 USD | $3.4M | SEC |
| May 10, 2023 | Sell | -150,000 | 34.50 USD | $5.2M | SEC |
| Apr 26, 2023 | Sell | -200,000 | 29.12 USD | $5.8M | SEC |
| Apr 6, 2023 | Sell | 200,000 | 31.25 USD | $6.3M | SEC |
| Apr 6, 2023 | Sell | -200,000 | 31.25 USD | $6.3M | SEC |
| Aug 19, 2022 | Buy | -30,684 | 13.87 USD | $425.6K | SEC |
| Jul 25, 2022 | Sell | -34,658 | 11.21 USD | $388.5K | SEC |
| Jun 28, 2022 | Sell | -34,658 | 11.76 USD | $407.6K | SEC |
| Sep 21, 2021 | Buy | 34,658 | 10.96 USD | $379.9K | SEC |